FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine, namely to nephrology, and can be used for the purpose of early diagnosis of sarcopenia in people with stage 5D chronic kidney disease receiving treatment with long-term hemodialysis. The stage of protein-energy deficiency is determined using a complex technique, as well as the amount of points according to the SARC-F questionnaire, the muscle strength based on the results of right hand dynamometry, the amount of meters walked according to the results of a 6 minute walk test, the level of creatinine and indoxyl sulphate. The coefficient of probability of the presence of sarcopenia in the patient is calculated based on the original calculation formula, according to the developed diagnostic model. If the level of the coefficient is equal to or more than 0.65, the patient is diagnosed with sarcopenia, if the coefficient is less than 0.65, sarcopenia is ruled out.
EFFECT: method provides a possibility of increasing the accuracy of early diagnostics of sarcopenia in people with stage 5D chronic kidney disease by developing a diagnostic model of sarcopenia.
1 cl, 1 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DIAGNOSTICS OF PROTEIN-ENERGY INSUFFICIENCY IN ADULT PATIENTS WITH STAGE 3A-5D CHRONIC KIDNEY DISEASE | 2021 |
|
RU2770551C1 |
METHOD FOR PREDICTING SARCOPENIA IN PATIENTS RECEIVING CHRONIC HEMODIALYSIS TREATMENT | 2023 |
|
RU2811653C1 |
METHOD FOR SCREENING SARCOPENIA IN A PATIENT RECEIVING PROGRAMMED HEMODIALYSIS | 2019 |
|
RU2710267C1 |
METHOD FOR DIAGNOSING SARCOPENIA IN ELDERLY AND SENILE PATIENTS | 2017 |
|
RU2666119C1 |
METHOD FOR IMPROVING PHYSICAL PERFORMANCE OF PATIENTS WITH ISCHEMIC HEART DISEASE AND OSTEOSARCOPENIA IN CORONARY ARTERY BYPASS SURGERY | 2021 |
|
RU2768470C1 |
METHOD FOR DETERMINING SARCOPENIA USING A QUANTITATIVE ASSESSMENT OF MUSCLE TISSUE ACCORDING TO COMPUTER TOMOGRAPHY OF THE CHEST | 2020 |
|
RU2754291C1 |
METHOD FOR THE DIAGNOSIS OF SARCOPENIA IN ELDERLY AND SENILE PATIENTS | 2019 |
|
RU2713905C1 |
METHOD FOR DETERMINING RISK OF DEVELOPING PRESARCOPENIA | 2023 |
|
RU2824090C1 |
METHOD FOR DETERMINING MUSCLE MASS INDEX AT LEVEL OF Th VERTEBRA ACCORDING TO COMPUTED TOMOGRAPHY DATA IN ABSENCE OF INFORMATION ABOUT PATIENT'S HEIGHT | 2022 |
|
RU2804240C1 |
NON-INVASIVE DIAGNOSTIC TECHNIQUE FOR TUBULOINTERSTITIAL FIBROSIS ACCOMPANYING FOCAL SEGMENTAL GROMELUROSCLEROSIS | 2014 |
|
RU2575826C2 |
Authors
Dates
2021-09-28—Published
2020-11-13—Filed